Outgoing and structured people coped best with the pandemic
It looked like the COVID-19 pandemic might be a good time to be an introvert. Now a large study shows that extroverts handled the situation better.
It looked like the COVID-19 pandemic might be a good time to be an introvert. Now a large study shows that extroverts handled the situation better.
At least six million people have died from COVID-19 to date. But who dies is often not random. The same pattern is found around the world.
The ability of gold particles to reflect light in different colours is used in applications from stained glass to pregnancy tests. Now researchers are set to exploit the same properties in an ultra-fast sensor for the coronavirus.
Physically active people who increased their activity level early on in the pandemic had poorer mental health than those who delayed increasing their exercise.
The RS virus more often leads to hospitalizations in children than the coronavirus alone. New research results show that fewer children who get both the rhinovirus and corona appear to get seriously sick than kids who contract corona alone.
Some occupations got a lot busier when COVID-19 hit. Sleep and quality of life for many workers in essential occupations have been strongly impacted.
For the first time, raw data on Norwegian coronavirus genes will be freely available through the open gene bank ENA.
The fight against COVID-19 is far from over. A new combination of drugs could help save lives.
Norwegians are unspeakably tired of the measures imposed by the country’s Minister of Health, Bent Høie. But historian Erik Opsahl says the measures are mild compared to the old days. Imported infection during pandemics used to be stopped by gunfire.
NTNU researchers are on track to find drug combinations that could help stop the coronavirus across the globe.
The new vaccines designed to combat the Covid-19 virus have been developed in record time, causing some people to be sceptical of taking them. Should we be worried about side effects? Norwegian SciTech News has been talking to two research scientists about this issue.
Pfizer has recently announced that it is ready with a Covid-19 vaccine that is 90 percent effective. The vaccine is a so-called mRNA vaccine that has been developed jointly by Pfizer and BioNTech. But what is mRNA technology, and how does it work?
Quite a lot of people have modified their exercise habits during the pandemic, but that didn’t affect sleep quality for active people.
The Norwegian University of Science and Technology (NTNU) has signed agreements to deliver as many as one million COVID-19 test kits to DTU, the Technical University of Denmark, and APS LABS, an Indian biotech company. “It is very positive that this technology can now also be useful internationally,” says Bent Høie, Norway’s Minister of Health and Care Services.
One combination of two drugs was so effective that researchers hope others can begin clinical trials on the drugs now.
Testing families of four or more people would be an effective way to reduce the spread of the coronavirus infection, according to a data simulation model developed at NTNU. The model has initially been used to determine the best testing strategy for Oslo.
NTNU researchers recently figured out a whole new method for testing people for the coronavirus. The university is now producing tests on a continuous basis, under the auspices of the Norwegian Directorate of Health. Currently 100 000 tests a day are being manufactured, with production soon likely to be scaled up dramatically.
Italy’s budget deficit is skyrocketing. Yet people there are not debating the cost of a human life, or whether the shutdown of the country is worth it.
Two weeks ago, doctors at St. Olavs Hospital in Trondheim were running out of reagents needed to do COVID-19 tests. They asked colleagues at NTNU to develop a backup solution. Now, Norway is gearing up to use the new approach to test 150,000 people a week after Easter.